FDA Approves Expanded Use Of Gliadel Wafer (Polifeprosan 20 With Carmustine Implant) For Primary Malignant Brain Cancer | DocGuide

Auto-generated: February 12 2012 07:54 PM GMT-8

187

Stars

Star This?

Source: DGNews | Posted 8 years ago

FDA Approves Expanded Use Of Gliadel Wafer (Polifeprosan 20 With Carmustine Implant) For Primary Malignant Brain Cancer

Tags:

Read/Add Comments | Email This | Print This

BALTIMORE, MD -- February 26, 2003 -- Guilford Pharmaceuticals Inc. (Nasdaq: GLFD) announced today that the Company's marketed product, Gliadel

187

Stars

Star This? Yes / No

Comments
To post a comment, please sign in or register as a physician.

Terms of Use | Privacy Policy

© All Content Copyright 1995 - 2012 Doctor's Guide Publishing Limited. All Rights Reserved.